Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. - sprookjes - yvandenbroek - TriplyDB

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

http://www.wikidata.org/entity/Q35207795

about

Extracellular matrix associated protein CYR61 is linked to prostate cancer development Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets Cancer Stem Cell Hierarchy in Glioblastoma Multiforme MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management Emerging critical role of molecular testing in diagnostic genitourinary pathology MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes Concurrent HDAC and mTORC1 inhibition attenuate androgen receptor and hypoxia signaling associated with alterations in microRNA expression Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism MYC on the path to cancer Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting.Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.Evaluation of the 8q24 prostate cancer risk locus and MYC expression.Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.MYC association with cancer risk and a new model of MYC-mediated repression.Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.Mouse models of prostate cancer: picking the best model for the question.Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells Molecular genetics of prostate cancer: new prospects for old challenges Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Luminal cells are favored as the cell of origin for prostate cancer Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy.Molecular pathways and targets in prostate cancer Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.Claudin-4 levels are associated with intact alveolar fluid clearance in human lungs.Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer

P2860

Q24623715-62CEFE60-0D42-4D3B-896C-B78891AB0C8E Q24629083-2F44DA53-6053-4117-AA56-DAEDF8C2F5F6 Q26752312-75A34786-4D99-42B2-A777-1E82EBCD215C Q26785379-4C24466A-7D7E-4088-8CCF-2B0EA4C75B67 Q27021371-7FFDBB17-E701-4D6F-A76C-3FEE9D556F53 Q27350187-0B32198A-7C09-4220-8CE9-4190B818178D Q28085759-D2C142E7-42D3-4173-9638-3B5C7C8979AB Q28743074-46364354-A7F6-44A8-956E-DE3F7E15143C Q28831339-FDBFD520-4A62-4BA5-A363-127A7E565FFB Q29617213-BF2375C9-9C4C-488D-98C5-7B30557E0E90 Q29619979-AC097041-2926-4125-97B9-1B292AA88CC6 Q30409623-25C7AB34-5375-410B-9883-948914CDDEB6 Q30413042-31B8D08D-B9E6-40E7-84C6-50F48049AE99 Q30494853-CC2F5EED-A9F6-4908-9C84-C8B3D970250B Q30866782-8C34068D-24C5-470E-8BDB-CD9E75A4CE60 Q33535955-F7E3E1D5-854A-488D-94BF-8E4493F3D251 Q33685303-32B94EBA-C974-430B-AD5C-1B319F245809 Q33728316-AA7A430D-DD0E-4F7E-A740-69FCA97DD2EB Q33790662-ACD02094-D96B-4D74-A937-57A7793B3951 Q33808309-EB3FBD95-B2B0-4F5A-8C9C-9FBBFD073120 Q33816335-47706EF3-8822-400D-BA0F-120EFC7E11CE Q33893647-DA09E16E-8434-4117-804C-CB4580B8A46A Q33936343-E3F8BCC8-E7F7-457E-BF58-0D681DE5E758 Q33940867-AC4C086E-65D3-4D1D-BF38-E19BE22497AB Q33952990-E44CE102-07FA-4B03-9CC0-17B6E0503097 Q34000188-6263CC59-6076-474B-B1EB-85E99B384815 Q34078067-CD3869D0-2500-4317-A3C5-1D8E26267F73 Q34109986-633CBF31-B2DF-4A30-8741-1ECBA722C184 Q34119201-F82D223C-AAE8-4ED3-9C76-34657A5F0B9C Q34126555-D4331D7E-65D6-4FA9-9AE5-2AF5E1FAC181 Q34127462-9E0A4500-8554-4FB9-8CF7-2F7A121CA05F Q34173253-B009F1BA-2265-4F66-A400-D636A81E6DCC Q34175508-1A57D4CE-3CD5-457A-9332-A25016366D6A Q34284930-B03C4BD3-2EF0-4B9E-A60F-4043639DD53F Q34365632-708930A1-61F8-476D-8686-35D0AE806E12 Q34495620-B589BD1E-E882-414D-A3EF-ED76E96F62D2 Q34805348-037FA25C-C1DB-4021-A0F9-0E50AD7F7DCA Q35103979-D07ADE41-9408-4846-9396-36923E0245FB Q35167870-02D91B30-F2AB-4D31-8482-94BE2CBFA980 Q35406347-CB99AB5D-9FC3-483C-8AFE-715B85B8B6F0

P2860

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.

http://www.wikidata.org/entity/Q35207795

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@ast

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@en

type

label

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@ast

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@en

prefLabel

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@ast

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@en

P1433

Q35207795-B206BAFD-D827-467C-9540-00A9CA3381F0

P1476

Q35207795-26C27A0D-EA7F-4650-869F-4BD33C6A36BC

P2093

Q35207795-0CBFFAE1-EE07-43A3-A8E4-D6D3ACFA7200

Q35207795-1BFCA46F-D358-4381-A020-03BD14010389

Q35207795-36947146-3667-4452-9F94-76317AD577AE

Q35207795-473E318A-F12C-4127-A535-4D3BBF578AD3

Q35207795-83EAC339-ECBB-4669-BF3F-5821050EC0E3

Q35207795-8A0DD967-B50F-411C-98B7-EA42C38038ED

Q35207795-B02A68FA-9963-43EB-9246-4CEB5B8D1F1A

Q35207795-B3BF83DC-B8D7-4F73-84F2-5B14E54A5C85

Q35207795-CB248CC4-08D7-4A0F-93DD-41E90955D6AF

Q35207795-D1AA7959-9F8A-4F2E-8D34-7F961785B530

P2860

Q35207795-05146DC0-6988-4460-85A0-66E58188DD21

Q35207795-06BD14FC-4F70-4B9C-AC4F-141526B8CE4A

Q35207795-124ACD8B-42F9-49A9-A8E2-B59386B5A207

Q35207795-1B04924E-4FD7-47BE-933A-DE837FBFE967

Q35207795-315ADA34-BA1D-4EA4-983B-178CE123D22E

Q35207795-3BDFC90F-978B-47A8-99EE-23444AF919B2

Q35207795-3D3C885A-8672-4892-A4B3-E6FCA29D4CD5

Q35207795-4B441935-E0BE-40CC-9C93-5C476126E49A

Q35207795-4C24852F-66CD-4188-9389-DE9C3FC28AF5

Q35207795-53E3DE5C-DE89-4C26-B30F-D5EAE4DF2F13

P2888

Q35207795-0F4439B8-FCED-44FC-A07D-5A033C8C1C8A

P304

Q35207795-22746A6B-EF54-4FFC-81DD-EF7C3264F31D

P31

Q35207795-5F3AB404-4E81-407C-BB08-5C303E8D6C3F

P356

Q35207795-D60BFB23-A7B6-4AE0-A7B1-3808196EB73C

P433

Q35207795-884299B9-E106-4FB4-B8F4-BB01FB70C91D

P478

Q35207795-FA6D0CD7-26DA-45AD-81C1-8FBD6F569F5E

P577

Q35207795-BC0C7DB0-5B96-4789-A71D-1365246E33F6

P5875

Q35207795-92683153-9FAC-4647-BA7F-96CFFCC29BDE

P6179

Q35207795-D5BF288B-356B-4FEF-8364-43BCDCC7220C

P698

Q35207795-1259DFC7-A830-4D98-AF1A-DC3CC00E7167

P921

Q35207795-EFCC7629-3276-48EC-837E-F51A3CF6E57D

P932

Q35207795-BF66E409-D7BE-4D48-8F0B-10122E0C5818

P356

MODPATHOL.2008.111

P1433

Modern Pathology

P1476

Nuclear MYC protein overexpres ...... human prostate carcinogenesis.

@en

P2093

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

Bora Gurel

http://www.w3.org/2001/XMLSchema#string

Cheryl M Koh

http://www.w3.org/2001/XMLSchema#string

Chi Van Dang

http://www.w3.org/2001/XMLSchema#string

Fusheng Lan

http://www.w3.org/2001/XMLSchema#string

James Morgan

http://www.w3.org/2001/XMLSchema#string

Jessica L Hicks

http://www.w3.org/2001/XMLSchema#string

Jun Luo

http://www.w3.org/2001/XMLSchema#string

Robert B Jenkins

http://www.w3.org/2001/XMLSchema#string

Siobhan Sutcliffe

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer

c-Myc localization within the nucleus: evidence for association with the PML nuclear body

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

Integrative molecular concept modeling of prostate cancer progression.

MYC oncogenes and human neoplastic disease.

Molecular genetics of prostate cancer.

Focus on prostate cancer.

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

P2888

modpathol.2008.111

P304

1156-1167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2008.111

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5288577

http://www.w3.org/2001/XMLSchema#string

P6179

1013791579

http://www.w3.org/2001/XMLSchema#string

P698

18567993

http://www.w3.org/2001/XMLSchema#string

P921

P932

3170853

http://www.w3.org/2001/XMLSchema#string